Introducing the 2018-19 Breast Cancer Research Trainee Scholarships

The 2018-19 Breast Cancer Research Trainee Scholarships

Share

Supported by your generous donations the Breast Cancer Society of Canada has been able to continue our commitment to the Translational Breast Cancer Research Unit at the London Health Sciences Centre. The program provides funding to translational research focused on the understanding, prevention, tracking and treatment of metastatic breast cancer. BCSC would like to extend our congratulations to this years 14 scholarship recipients from Western University. Below is the message announcing this years scholarship recipients from Alison Allan, the Senior Oncology Scientist and Director of the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit part of the London Regional Cancer Program at the London Health Sciences Centre.

Dear Colleagues

I am delighted to announce 14 new graduate student scholarships at Western University for the 2018-2019 academic year.  These awards are supported by the Breast Cancer Society of Canada’s very generous commitment to the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit (TBCRU) at London Health Sciences Centre’s London Regional Cancer Program (LRCP).

Trainees compete annually for these awards.  Their applications are assessed by a scientific review committee based on the quality and translational potential of their project, their academic record, and the strength of their mentor/training environment  Seven PhD students and seven MSc students were selected for awards this year.  These students are enrolled in five different departments/programs at Western (Anatomy & Cell Biology, Biochemistry, Biomedical Engineering, Medical Biophysics, and Pathology & Laboratory Medicine) and are from two Western Faculties (Schulich and Engineering).  The trainees are working in research laboratories located at LRCP, St. Joseph’s Health Care London, Robarts, and Western.

Their translational research projects are broadly focused on the understanding, prevention, tracking and/or treatment of metastatic breast cancer, the most deadly aspect of breast cancer. Descriptions of the 14 projects can be found on the Translational Breast Cancer Research Unit pages.

You can read more about the TBCRU and its history on the website also.

Over the coming year, we encourage you to support the TBCRU Traineeship Program through Breast Cancer Society of Canada community events including Dress for the Cause and the Mother’s Day Walk. You can also read about our students and their research progress throughout the year on the BCSC website.

Congratulations to our trainees and best wishes to them as they contribute to breast cancer research at Western!

Alison L. Allan, PhD
Senior Oncology Scientist and Director, Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit
London Regional Cancer Program, London Health Sciences Centre

Support researchers like these from the TBCRU and others by considering a donation to the Breast Cancer Society of Canada. Find out how you can help fund life-saving research, visit bcsc.ca/donate

 

Related Articles

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.